Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy
Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy have?
Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy has 15 citations in the OpenAlex counts ScholarIQ stores.
When was Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy published?
Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy has 2024 year in the ScholarIQ index.
What is the open-access status of Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy?
Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy has gold oa status in the ScholarIQ index.
What is the DOI of Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy?
The DOI for Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy is on the source record.
What is the PMID of Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy?
The PMID for Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy is on the source record.
What is the OpenAlex record for Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy?
The OpenAlex for Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy is on the source record.